148 related articles for article (PubMed ID: 23957015)
21. Involvement of glomerular SREBP-1c in diabetic nephropathy.
Ishigaki N; Yamamoto T; Shimizu Y; Kobayashi K; Yatoh S; Sone H; Takahashi A; Suzuki H; Yamagata K; Yamada N; Shimano H
Biochem Biophys Res Commun; 2007 Dec; 364(3):502-8. PubMed ID: 17961514
[TBL] [Abstract][Full Text] [Related]
22. Non-purine selective xanthine oxidase inhibitor ameliorates glomerular endothelial injury in Ins
Itano S; Kadoya H; Satoh M; Nakamura T; Murase T; Sasaki T; Kanwar YS; Kashihara N
Am J Physiol Renal Physiol; 2020 Nov; 319(5):F765-F772. PubMed ID: 32954851
[TBL] [Abstract][Full Text] [Related]
23. Calcium channel blocker enhances beneficial effects of an angiotensin II AT1 receptor blocker against cerebrovascular-renal injury in type 2 diabetic mice.
Rafiq K; Sherajee SJ; Hitomi H; Nakano D; Kobori H; Ohmori K; Mori H; Kobara H; Masaki T; Kohno M; Nishiyama A
PLoS One; 2013; 8(12):e82082. PubMed ID: 24339994
[TBL] [Abstract][Full Text] [Related]
24. Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.
Elmarakby AA; Faulkner J; Al-Shabrawey M; Wang MH; Maddipati KR; Imig JD
Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1307-17. PubMed ID: 21832210
[TBL] [Abstract][Full Text] [Related]
25. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
[TBL] [Abstract][Full Text] [Related]
26. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.
Ju KD; Shin EK; Cho EJ; Yoon HB; Kim HS; Kim H; Yang J; Hwang YH; Ahn C; Oh KH
Am J Physiol Renal Physiol; 2012 Mar; 302(5):F606-13. PubMed ID: 22129969
[TBL] [Abstract][Full Text] [Related]
27. HIF-1 Mediates Renal Fibrosis in OVE26 Type 1 Diabetic Mice.
Nayak BK; Shanmugasundaram K; Friedrichs WE; Cavaglierii RC; Patel M; Barnes J; Block K
Diabetes; 2016 May; 65(5):1387-97. PubMed ID: 26908870
[TBL] [Abstract][Full Text] [Related]
28. NADPH oxidase NOX1 is involved in activation of protein kinase C and premature senescence in early stage diabetic kidney.
Zhu K; Kakehi T; Matsumoto M; Iwata K; Ibi M; Ohshima Y; Zhang J; Liu J; Wen X; Taye A; Fan C; Katsuyama M; Sharma K; Yabe-Nishimura C
Free Radic Biol Med; 2015 Jun; 83():21-30. PubMed ID: 25701431
[TBL] [Abstract][Full Text] [Related]
29. Effects of NADPH oxidase inhibitor in diabetic nephropathy.
Asaba K; Tojo A; Onozato ML; Goto A; Quinn MT; Fujita T; Wilcox CS
Kidney Int; 2005 May; 67(5):1890-8. PubMed ID: 15840036
[TBL] [Abstract][Full Text] [Related]
30. The roles of NADPH-oxidase and nNOS for the increased oxidative stress and the oxygen consumption in the diabetic kidney.
Edlund J; Fasching A; Liss P; Hansell P; Palm F
Diabetes Metab Res Rev; 2010 Jul; 26(5):349-56. PubMed ID: 20583310
[TBL] [Abstract][Full Text] [Related]
31. Expression and regulation of a novel identified TNFAIP8 family is associated with diabetic nephropathy.
Zhang S; Zhang Y; Wei X; Zhen J; Wang Z; Li M; Miao W; Ding H; Du P; Zhang W; He M; Yi F
Biochim Biophys Acta; 2010 Nov; 1802(11):1078-86. PubMed ID: 20699119
[TBL] [Abstract][Full Text] [Related]
32. The Absence of the ACE N-Domain Decreases Renal Inflammation and Facilitates Sodium Excretion during Diabetic Kidney Disease.
Eriguchi M; Bernstein EA; Veiras LC; Khan Z; Cao DY; Fuchs S; McDonough AA; Toblli JE; Gonzalez-Villalobos RA; Bernstein KE; Giani JF
J Am Soc Nephrol; 2018 Oct; 29(10):2546-2561. PubMed ID: 30185469
[TBL] [Abstract][Full Text] [Related]
33. Adrenomedullin mediates early phase angiogenesis induced diabetic nephropathy in STZ diabetic rats.
El Eter EA; Al-Masri AA
Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3534-43. PubMed ID: 25491634
[TBL] [Abstract][Full Text] [Related]
34. Role of Nox2 in diabetic kidney disease.
You YH; Okada S; Ly S; Jandeleit-Dahm K; Barit D; Namikoshi T; Sharma K
Am J Physiol Renal Physiol; 2013 Apr; 304(7):F840-8. PubMed ID: 23389458
[TBL] [Abstract][Full Text] [Related]
35. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat.
Zimpelmann J; Kumar D; Levine DZ; Wehbi G; Imig JD; Navar LG; Burns KD
Kidney Int; 2000 Dec; 58(6):2320-30. PubMed ID: 11115066
[TBL] [Abstract][Full Text] [Related]
36. Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor.
Okazaki Y; Yamasaki Y; Uchida HA; Okamoto K; Satoh M; Maruyama K; Maeshima Y; Sugiyama H; Sugaya T; Kashihara N; Makino H
Clin Exp Nephrol; 2007 Mar; 11(1):77-87. PubMed ID: 17385003
[TBL] [Abstract][Full Text] [Related]
37. Gonadectomy prevents the increase in blood pressure and glomerular injury in angiotensin-converting enzyme 2 knockout diabetic male mice. Effects on renin-angiotensin system.
Clotet S; Soler MJ; Rebull M; Gimeno J; Gurley SB; Pascual J; Riera M
J Hypertens; 2016 Sep; 34(9):1752-65. PubMed ID: 27379538
[TBL] [Abstract][Full Text] [Related]
38. Intrarenal dopamine inhibits progression of diabetic nephropathy.
Zhang MZ; Yao B; Yang S; Yang H; Wang S; Fan X; Yin H; Fogo AB; Moeckel GW; Harris RC
Diabetes; 2012 Oct; 61(10):2575-84. PubMed ID: 22688335
[TBL] [Abstract][Full Text] [Related]
39. Bone Morphogenetic Protein 4 and Smad1 Mediate Extracellular Matrix Production in the Development of Diabetic Nephropathy.
Matsubara T; Araki M; Abe H; Ueda O; Jishage K; Mima A; Goto C; Tominaga T; Kinosaki M; Kishi S; Nagai K; Iehara N; Fukushima N; Kita T; Arai H; Doi T
Diabetes; 2015 Aug; 64(8):2978-90. PubMed ID: 25995358
[TBL] [Abstract][Full Text] [Related]
40. Upstream regulators and downstream effectors of NADPH oxidases as novel therapeutic targets for diabetic kidney disease.
Gorin Y; Wauquier F
Mol Cells; 2015 Apr; 38(4):285-96. PubMed ID: 25824546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
